𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combined radiation and chemotherapy for advanced undifferentiated nasopharyngeal carcinoma in children

✍ Scribed by Strojan, Primož; Benedik, Majda Dolničar; Kragelj, Borut; Jereb, Berta


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
96 KB
Volume
28
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

✦ Synopsis


Five children, 11-16 years of age at diagnosis, with advanced (stage IV) undifferentiated nasopharyngeal carcinoma, are reviewed. All had radiotherapy and chemotherapy, four at first treatment, are disease free in 8 months, 6, 10, and 13 years from diagnosis. One patient who had radiotherapy only as primary treatment and chemotherapy for metastases, died 15 months from diagnosis. One patient who received 60 Gy and chemotherapy according to the BACON protocol had severe early toxic-ity and severe late sequelae of treatment. Three patients who received chemotherapy according to a modified UICC-2 protocol for nasopharyngeal carcinoma and 50 to 54 Gy to the primary site had only mild early toxicity and mild late effects of treatment. With lower radiation doses, adjusted to the effect of preradiation chemotherapy, complete tumor control was achieved and acute and long-term morbidity reduced.


📜 SIMILAR VOLUMES


Cyclophosphamide, doxorubicin, and cispl
✍ Arnon I. Dreyfuss; John R. Clark; Barbara G. Fallon; Marshall R. Posner; Charles 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB 👁 1 views

Thirteen patients with carcinomas of major and minor salivary gland origin (nine adenoid cystic carcinomas and four adenocarcinomas) were treated with cyclophosphamide (500 mg/m2), doxorubicin (50 mg/m2), and cisplatin (50 mg/m2) (CAP) by intravenous injections on the first day of a 28-day regimen.

Paclitaxel, 5-fluorouracil, and cisplati
✍ Yeul H. Kim; Sang W. Shin; Byung S. Kim; Jin H. Kim; Jong G. Kim; Young J. Mok; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 1 views

## Background: Although the clinical efficacy of paclitaxel in the treatment of gastric carcinoma has not been clearly defined, recent reports have suggested a possible role in the treatment of upper gastrointestinal carcinomas in vitro and in vivo. in this study, the authors evaluated the efficacy